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Since the very beginning of medicine, physicians have realized
that the clinical course of infections varies greatly among
individuals. They gradually recognized that both host and
pathogen genetic determinants could play critical roles in the
progress of the infectious disease and its clinical outcome.
Until recently, however, the number of studies focused on
establishing the molecular characteristics controlling the
pathogenicity of the microorganism have greatly outnumbered
those aimed at establishing the host genetic determinants
affecting the natural course of infectious diseases.
In recent years, the situation has suddenly changed, and the
last decade has seen the publication of a huge number of
studies designed to identify the host genetic determinants
specifically affecting host susceptibility and the outcome of
certain infectious diseases. By the use of various approaches
(mainly candidate gene approaches, genome-wide association
studies, and large-scale in vitro genome screens), host genetics
have been convincingly associated with the control of and/or
the resistance to specific infections [1–3]. Consequently, we
now definitely know that specific genomic determinants of
susceptibility to infections and the progression of infectious
diseases do exist. The same conclusions can be reached when
the inter-individual variation in antimicrobial drug response is
examined. Again, it has been clearly established that the
variability observed in humans may depend on host determi-
nants [4,5].
The present themed section of Clinical Microbiology and
Infection is aimed at describing the main examples of the
contribution of host genetic factors to susceptibility to viral,
bacterial, fungal and parasitic infections. A number of examples
of the main consolidated genetic determinants of the natural
history of infectious diseases that are currently accepted and,
in a few cases, already applied in clinical practice will be
reviewed. Some understudied issues that might prove to be
fruitful areas for further research into host genetics and
infections will be also highlighted.
Specifically, the first review, by Riva et al. [6], as an example
of host genetics and viral infection, describes the existence of a
very complex interplay between the host’s genetic, biochem-
ical, inflammatory and immune factors, among which inter-
feron (IFN)-k, alternatively known as interleukin-28, finally
leads to the regulation of the response to hepatitis C infection.
The review discusses the discovery of a completely new and
unexpected way to consider the response to IFN therapy,
which, in a still unknown manner, combines the action of
IFN-k3 and IFN-k4.
The second review, by Asner et al. [7], based on an
extensive electronic-based search, clearly supports the pivotal
role of genetic factors in the clinical presentations and severity
of infections caused by intracellular and/or fastidious bacteria
such as chlamydiae (Chlamydia trachomatis, Chlamydia psittaci,
and Chlamydia pneumoniae), Mycoplasma pneumoniae, Coxiella
burnetii, and Tropheryma whipplei, other than that caused by
Mycobacterium tuberculosis. The review specifically deals with
the host immune determinants evoked during the microor-
ganism-elicited immune response, which may affect the
susceptibility to bacterial diseases.
Then, Pana et al. [8] summarize our current knowledge on
host monogenetic defects and genetic polymorphisms asso-
ciated with a predisposition to acquire or the severity of
opportunistic fungal diseases, mainly superficial and invasive
candidiasis, and aspergillosis. This knowledge may eventually
contribute to a better understanding of the mechanism of
superficial and invasive fungal disease and to the development
of disease biomarkers. The detection of accurate biomarkers
could help in targeting individuals for prophylactic therapy,
and tailoring supportive care according to individual risk
profiles in order to ultimately improve quality of life, reduce
costs, and avoid unnecessary and sometimes toxic antifungal
therapy.
Last, but not least, Mangano and Modiano [9] provide a very
comprehensive and updated review of the human genetic
factors affecting the course of parasitic diseases, such as
malaria, leishmaniasis, trypanosomiasis, schistosomiasis, hel-
minthiasis, and filariasis. Of particular interest is the discussion
on the potential role of parasites in driving the evolution of the
human immune system. Indeed, there is accumulating evidence
that some of the host loci for susceptibility are shared not only
by parasitic diseases, but also by immunological disorders, such
as allergic and autoimmune diseases. This opens new and
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fascinating perspectives on the role of the microorganisms in
human evolution.
We believe that the present series of minireviews on host
genetics and infection, written by expert microbiologists,
immunologists, and infectious disease researchers, is particu-
larly interesting and challenging. The structure and the
terminology may, in some instances, appear unusual but, in
the meantime, the specific expertise of the authors allows
detailed discussion of the complexity of the pathways that
underlie the genetic association and its potential molecular
mechanisms. Clinicians must be aware that we are far from
having a complete understanding of the response of the host to
microbial stimuli. We only know that such a response depends
on a coordinated gene expression plan involving the tran-
scription of thousands of genes, and possibly also involving
epigenetic changes, mechanisms, and/or expression of specific
microRNAs [10,11]. Addressing the ‘host genetics and infec-
tious diseases’ topic in a proper way would mean fully
considering that what we are looking at is a small part of a
complex programme that, in its entirety, explains the marked
differences in susceptibility to infectious diseases observed
among individuals.
Despite the importance of the above issues, there are
many reasons for continuing to address host genetic factors
in order to identify determinants that are capable of altering
the expression levels of immune-related genes and elucidate
their mechanisms of association. Indeed, carrying out such
studies may have important implications: (i) to predict disease
risk, i.e. to define individual risks for a severe course of
infection and then stratify human populations for risk of
disease; (ii) to provide insights into the study of the
pathogenesis of some infections where the host–microor-
ganism interaction is complex and/or still unknown; (iii) to
understand the cause of resistance to infections, which may
support the development of new antimicrobial agents and
vaccines; and (iv) finally, and probably far from the micro-
biologists and infectious disease specialists, to study the
influence of microorganisms in generating and/or maintaining
the diversity of humans.
In conclusion, we believe that, although a great number of
very important issues must still be addressed, the minireviews
of this themed section may help to further emphasize the
current concept that the variability in the susceptibility to
infectious diseases and their clinical manifestations can be
determined not only by variations in the environment and in
the molecular characteristics of the pathogen, but also by
specific host genetic determinants.
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